{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:54:28Z","timestamp":1790272468377,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003508","name":"Universitat de Val\u00e8ncia","doi-asserted-by":"publisher","award":["GV\/2013\/086"],"award-info":[{"award-number":["GV\/2013\/086"]}],"id":[{"id":"10.13039\/501100003508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003508","name":"Universitat de Val\u00e8ncia","doi-asserted-by":"publisher","award":["UV-INV-PRECOMP12-80750"],"award-info":[{"award-number":["UV-INV-PRECOMP12-80750"]}],"id":[{"id":"10.13039\/501100003508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejpb.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T15:01:53Z","timestamp":1499871713000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model"],"prefix":"10.1016","volume":"119","author":[{"given":"Ana","family":"Melero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Draheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Talens-Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Mar\u00eda","family":"Garrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Esteban","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Carmen","family":"Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Michael","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejpb.2017.07.004_b0005","first-page":"1229","article-title":"Chronic inflammatory intestinal diseases","volume":"50","author":"Herrlinger","year":"2009","journal-title":"Pathophysiol. Therap. Internist."},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.14.354","article-title":"Treatment of inflammatory bowel disease: a review of medical therapy","volume":"14","author":"Kozuch","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejpb.2017.07.004_b0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1445-5994.2010.02163.x","article-title":"Advances in the management of inflammatory bowel disease","volume":"40","author":"Grimpen","year":"2010","journal-title":"Intern. Med J."},{"issue":"2","key":"10.1016\/j.ejpb.2017.07.004_b0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2012.01.028","article-title":"Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa","volume":"161","author":"Collnot","year":"2012","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"8","key":"10.1016\/j.ejpb.2017.07.004_b0025","first-page":"2609","article-title":"A design of experiment study of nanoprecipitation and nano spray drying as processes to prepare PLGA nano- and microparticles with defined sizes and size distributions","volume":"32","author":"Draheim","year":"2015","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.ejpb.2017.07.004_b0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11894-999-0008-4","article-title":"Cyclosporine in inflammatory bowel disease","volume":"1","author":"Kornbluth","year":"1999","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2017.07.004_b0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.gastro.2007.05.006","article-title":"American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21\u201323, 2006","volume":"133","author":"Clark","year":"2007","journal-title":"Gastroenterology"},{"issue":"183","key":"10.1016\/j.ejpb.2017.07.004_b0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2014.03.039","article-title":"Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases","volume":"10","author":"Ali","year":"2014","journal-title":"J. Control. Release Off. J. Control Release Soc."},{"issue":"6","key":"10.1016\/j.ejpb.2017.07.004_b0050","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.07.004_b0055","first-page":"1","article-title":"Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa \u2013 a first in vivo study in human patients","author":"Schmidt","year":"2012","journal-title":"J. Controll. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2017.07.004_b0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2014.07.009","article-title":"Ucakar B, des Rieux A, Pr\u00e9at V. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease","volume":"473","author":"Beloqui","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.07.004_b0065","first-page":"561","article-title":"Crohn\u2019s disease: transmission electron microscopic studies. I. Barrier function. Possible changes related to alterations of cell coat, mucous coat, epithelial cells, and Paneth cells","volume":"11","author":"Dvorak","year":"1980","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gut.2006.098160","article-title":"Comparative study of the intestinal mucus barrier in normal and inflamed colon","volume":"56","author":"Swidsinski","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.gastro.2009.11.003","article-title":"Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model","volume":"138","author":"Laroui","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ejpb.2017.07.004_b0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejpb.2017.07.004_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.07.017","article-title":"Drug delivery to inflamed colon by nanoparticles: comparison of different strategies","volume":"440","author":"Coco","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jep.2013.09.030","article-title":"Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis","volume":"150","author":"Mar\u00edn","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.ejpb.2017.07.004_b0095","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.addr.2007.07.003","article-title":"Mouse models of inflammatory bowel disease","volume":"59","author":"Wirtz","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejpb.2017.07.004_b0100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.lfs.2013.01.028","article-title":"Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice","volume":"92","author":"Sann","year":"2013","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2017.07.004_b0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2017.07.004_b0110","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ibd.21557","article-title":"Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies","volume":"17","author":"Koboziev","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2017.07.004_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2007.05.028","article-title":"Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles","volume":"342","author":"Mladenovska","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2017.07.004_b0120","doi-asserted-by":"crossref","first-page":"e6073","DOI":"10.1371\/journal.pone.0006073","article-title":"Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis","volume":"4","author":"Yan","year":"2009","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.ejpb.2017.07.004_b0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3 Pt 1","key":"10.1016\/j.ejpb.2017.07.004_b0130","first-page":"G544","article-title":"Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis","volume":"274","author":"M\u00e4hler","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.ejpb.2017.07.004_b0135","doi-asserted-by":"crossref","first-page":"e30005","DOI":"10.1371\/journal.pone.0030005","article-title":"Modelling of mouse experimental colitis by global property screens: a holistic approach to assess drug effects in inflammatory bowel disease","volume":"7","author":"Gottfries","year":"2012","journal-title":"PloS One"},{"issue":"300","key":"10.1016\/j.ejpb.2017.07.004_b0140","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ejpb.2017.07.004_b0145","doi-asserted-by":"crossref","first-page":"G1328","DOI":"10.1152\/ajpgi.00467.2004","article-title":"Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: correlation between symptoms and inflammation","volume":"288","author":"Melgar","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.ejpb.2017.07.004_b0150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","article-title":"Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejpb.2017.07.004_b0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0022-3565(24)29290-9","article-title":"Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease","volume":"299","author":"Lamprecht","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2017.07.004_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.smim.2013.12.003","article-title":"Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development","volume":"26","author":"Waldner","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejpb.2017.07.004_b0165","first-page":"e271606","article-title":"C. Beneficial Effect of Shikonin on Experimental Colitis Induced by Dextran Sulfate Sodium in Balb\/C Mice","volume":"31","author":"Andujar","year":"2012","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"72","key":"10.1016\/j.ejpb.2017.07.004_b0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"7","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T23:39:48Z","timestamp":1750549188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117304563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":34,"alternative-id":["S0939641117304563"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.07.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}